Peijia Medical
Peijia Medical, officially known as Peijia Medical Technology Co., Ltd., is a leading innovator in the medical device industry, headquartered in China. Founded in 2015, the company has rapidly established itself as a key player in the development of advanced interventional medical devices, particularly in the fields of cardiovascular and neurovascular treatments. With a strong operational presence across Asia and expanding into global markets, Peijia Medical focuses on delivering cutting-edge solutions such as transcatheter aortic valve replacement (TAVR) systems and other minimally invasive technologies. Their commitment to research and development has led to significant milestones, including the successful launch of several proprietary products that enhance patient outcomes. Recognised for its innovative approach, Peijia Medical continues to strengthen its market position, contributing to the evolution of interventional therapies and improving the quality of care for patients worldwide.
DitchCarbon Score
How does Peijia Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Peijia Medical's score of 19 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Peijia Medical's reported carbon emissions
In 2023, Peijia Medical reported total carbon emissions of approximately 6,354,060 kg CO2e, with Scope 1 emissions at about 18,050 kg CO2e and Scope 2 emissions at approximately 6,336,000 kg CO2e. This marked an increase from 2022, where total emissions were about 3,612,910 kg CO2e, with Scope 1 at approximately 6,620 kg CO2e and Scope 2 at around 3,606,290 kg CO2e. In 2021, the company recorded total emissions of about 2,847,720 kg CO2e, with Scope 1 emissions of approximately 3,380 kg CO2e and Scope 2 emissions at about 2,844,340 kg CO2e. The emissions for 2020 were significantly lower, at around 853,530 kg CO2e, with Scope 1 emissions of about 2,120 kg CO2e and Scope 2 emissions of approximately 851,410 kg CO2e. Despite these figures, Peijia Medical has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of documented climate pledges or reduction targets suggests that the company may still be in the early stages of formalising its climate commitments. As the industry increasingly prioritises sustainability, Peijia Medical's future strategies will be crucial in addressing climate change and reducing emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 2,120 | 0,000 | 0,000 | 00,000 |
| Scope 2 | 851,410 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Peijia Medical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
